2篇
您的检索式：作者名="Ruilin Quan"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in China显示文摘Background: Coronary artery disease (CAD) is the commonest cause of heart failure (HF), whereas pulmonary hypertension (PH) has not been established or reported in this patient population. Therefore, we assessed the prevalence, risk factors, and survival in CAD-associated HF (CAD-HF) complicated with PH.Methods: Symptomatic CAD-HF patients were continuously enrolled in this prospective, multicenter registry study. Echocardiography, coronary arteriography, left and right heart catheterization (RHC), and other baseline clinical data were recorded. Patients were followed up and their survival was recorded.Results: One hundred and eighty-two CAD-HF patients were enrolled, including 142 with HF with a preserved ejection fraction (heart failure with preserved ejection fraction [HFpEF];left ventricular ejection fraction [LVEF] ≥50%) and 40 with a reduced ejection fraction (heart failure with reduced ejection fraction [HFrEF];LVEF < 50%). PH was diagnosed with RHC in 77.5% of patients. Patients with PH showed worse hemodynamic parameters and higher mortality. HFrEF-PH patients had worse survival than HFpEF-PH patients. CAD-HF patients with an enlarged left ventricular end-diastolic diameter and reduced hemoglobin were at higher risk of PH. Nitrate treatment reduced the risk of PH. Elevated creatinine and mean pulmonary arterial pressure (mPAP), diastolic pressure gradient (DPG) ≥7 mmHg, and previous myocardial infarction (MI) entailed a higher risk of mortality in CAD-HF patients with PH.Conclusions: PH is common in CAD-HF and worsens the hemodynamics and survival in these patients. Left ventricle enlargement and anemia increase the risk of PH in CAD-HF. Patients may benefit from nitrate medications. Renal impairment, elevated mPAP, DPG ≥7 mmHg, and previous MI are strong predictors of mortality in CAD-HF-PH patients.Trial Registration: ClinicalTrials.gov, NCT02164526. | Li Huang Lingpin Pang Qing Gu Tao Yang Wen Li Ruilin Quan Weiqing Su Weifeng Wu Fangming Tang Xiulong Zhu Jieyan Shen Jingzhi Sun Guangliang Shan Changming Xiong Shian Huang Jianguo He | 2022 | Chinese Medical Journal2022，，15： | 4 |
| 2 | Promoting the protonation step on the interface of titanium dioxide for selective photocatalytic reduction of CO_(2)to CH_(4)by using red phosphorus quantum dots显示文摘Enhancing the selectivity of hydrocarbon in CO_(2)is a great challenge.Herein,taking widely-used and highly-stable TiO_(2)as an example,we found that the protonation step,the key step for CH_(4)production,can change from endoergic to exoergic by using red phosphorus quantum dots.Consequently,the main product in CO_(2)reduction can be shifted from CO into CH_(4).The preparation method is very simple,which just ultrasonically treating the red P in the presence of TiO_(2).With an initial rate of CH_(4)production of 4.69μmol·g^(-1)·h^(-1),under simulated solar light,it manifests a significant 49.4-fold enhancement of CH_(4)yield over TiO_(2).Density functional calculation indicates that the red P optimizes the surface electronic structure.The Gibbs free energy for CHO^(*)formation(^(-1).12 eV)becomes lower than the desorption energy of the CO(-0.01 eV)when red P is introduced.This indicates that the CO intermediates on the surface are rapidly protonated to produce CHO^(*).Subsequently,the CHO^(*)will be converted into CH_(4)instead of being desorbed from the surface to produce CO.This study demonstrates that red P quantum dot is a promising candidate for the development of efficient photocatalyst for CO_(2)photoreduction to CH_(4)under solar light irradiation. | Yinglong Lu Minghao Liu Ningchao Zheng Xi He Ruiting Hu Ruilin Wang Quan Zhou Zhuofeng Hu | 2022 | Nano Research2022，15，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员